Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Inter Partes Reexamination Certificate (NIRC) and Conclusion of Reexamination Pr

2287 Conclusion of - 2200 Citation of Prior Art and Ex Parte Reexamination of Patents

http://www.uspto.gov/web/offices/pac/mpep/documents/2200_2287.htm

.

.

Be well

Share
New Message
Please login to post a reply